Drug Resistance in Tuberculosis Management: A Comprehensive Review

Abstract

TB remains a significant global health challenge. The emergence of drug-resistant strains of Mycobacterium tuberculosis has complicated TB management, posing substantial challenges to public health systems worldwide. This comprehensive review explores the mechanisms of drug resistance in TB, the implications for treatment, and the strategies being employed to combat this growing threat. Drug resistance in TB can be classified into primary and acquired resistance, with genetic mutations playing a crucial role in the development of resistance to both first-line and second-line anti-TB drugs. The review discusses the various types of drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), highlighting the prevalence of these strains in different regions and the socio-economic factors that contribute to their emergence. The impact of drug resistance on treatment outcomes is profound, necessitating longer and more complex treatment regimens that often involve second-line drugs with increased toxicity and lower efficacy. The economic burden of drug-resistant TB is significant, straining healthcare systems and affecting the productivity of individuals and communities. Advancements in diagnostic techniques, particularly molecular diagnostics, have revolutionized the detection of drug-resistant TB, enabling timely and appropriate treatment initiation. The review also examines innovative treatment strategies, including the use of novel anti-TB agents and shorter treatment regimens, which show promise in improving patient outcomes. Finally, the review emphasizes the importance of public health initiatives, community engagement, and international collaboration in addressing the challenges posed by drug-resistant TB. By understanding the complexities of drug resistance and implementing comprehensive strategies, we can work towards reducing the burden of TB and ultimately achieving the goal of eliminating this disease as a public health threat. This review serves as a critical resource for healthcare professionals, researchers, and policymakers involved in TB management and control.